ClinConnect ClinConnect Logo
Search / Trial NCT05713357

Repeated Endocardial Mapping for Efficacy Assessment After Catheter Ablation for Ischemic Ventricular Tachycardia

Launched by UNIVERSITY MEDICAL CENTRE LJUBLJANA · Jan 26, 2023

Trial Information

Current as of July 21, 2025

Enrolling by invitation

Keywords

Catheter Ablation Repeated Mapping

ClinConnect Summary

Patients with ischemic ventricular tachycardia and implanted defibrillatior (ICD) will be sent to catheter ablation according to current guidelines (ESC and/or HRS). At the initial procedure the scar will be mapped with an ablation catheter and a high density catheter and all abnormal endocardial electrical potentials will be marked on a three-dimensional electro-anatomical (3DEAM) map; late potentials, local abnormal ventricular activity and decrement evoked electrical potentials. Afterwards, programed ventricular stimulation will be performed with an intent to induce sustained ventricular...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • ischemic heart disease,
  • sustained ventricular tachycardia,
  • implanted (or scheduled for implantation) cardiac electrical device with ability to record and store intracardiac electrograms
  • Exclusion Criteria:
  • nonischemic cardiomyopathy,
  • need for epicardial access to the substrate for treatment of ventricular tachycardia,
  • any severe acute organ damage beyond cardiomyopathy that could potentialy omit remapping procedure after 3 months,
  • any terminal disease with expected survival of less than one year

About University Medical Centre Ljubljana

University Medical Centre Ljubljana (UMCL) is a leading academic medical institution in Slovenia, dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, UMCL integrates cutting-edge medical practices with comprehensive patient care, fostering an environment of collaboration among healthcare professionals, researchers, and patients. With a strong emphasis on ethical standards and scientific integrity, UMCL aims to contribute to the global body of medical knowledge while improving treatment outcomes in various therapeutic areas.

Locations

Ljubljana, , Slovenia

Patients applied

0 patients applied

Trial Officials

Matevž Jan, MD

Study Chair

University Medical Centre Ljubljana

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials